Check out your Company Bowl for anonymous work chats.
We are proud to share that results from our phase IV trial evaluating healthcare professional and patient experiences using our liquid, ready-to-use neuromodulator for the treatment of frown lines were published in the Journal of Cosmetic Dermatology. Read more here: https://bit.ly/3yVEma8
Rapid weight loss can impact facial skin in various ways. When coupled with changes in facial collagen, it can cause an aging phenomenon known as ‘facial melting.’ Yesterday, during our Instagram Live, ‘GAIN a Healthy Look When Losing Weight,’ on our dedicated GAINbyGalderma Instagram channel, we demonstrated how regenerative aesthetics can be used to treat facial melting. Hosted by renowned experts doctors Dr. Luiz Avelar and Dr. Priscilla Sarlos, these live sessions reflect Galderma’s commitment to science. We want to help the aesthetic community understand how rapid weight loss affects skin aging. And we want to show them how they can help patients address the changes they may be seeing in the mirror. My thanks to our teams in Brazil for organizing these learning experiences for the aesthetic community, supporting Galderma’s commitment to advancing dermatology for every skin story.
We are proud to share Galderma’s record-breaking results from the first quarter of 2024, and our first as a publicly listed company. For the first time in our history, we surpassed $1 billion in sales in the first three months of the year. This growth was delivered thanks to strong performances in all regions and all categories, especially injectable aesthetics, driven by executing on our proven Integrated Dermatology Strategy. Achieving this milestone demonstrates our steadfast commitment both to our growth journey and to delivering solutions that meet the needs of healthcare professionals, consumers and patients. It is also testament to the dedication of Galderma’s teams across the world.
Six products from Galderma’s portfolio of premium brands were recently designated as 2024 NewBeauty Award winners. The wins, ranging from our solutions in Dermatological Skincare and treatments in Injectable Aesthetics, underscore our strategy to leverage the latest in science to advance dermatology for every skin story: - Restylane® Eyelight won Best Filler for Under-Eye Hollows - Restylane® Kysse won Best Filler for Fuller Lips - Sculptra® won Best Collagen-Stimulating Injectable - ALASTIN® Skincare C-RADICAL Defense Antioxidant Serum won Best Vitamin C Serum - Cetaphil® Gentle Skin Cleanser won Best Cleanser for Sensitive Skin - Differin Acne Clearing Body Wash won Best Body Wash for Acne-Prone Skin NewBeauty Award winners are handpicked via a rigorous and demanding selection process. A panel of industry experts, doctors and magazine editors sort through thousands of submissions to identify the best of the best. In fact, products and treatments undergo over six months of meticulous screening, including 200 hours of use and multiple rounds of testing and analysis. It’s an honor to be recognized by a title that’s trusted by both consumers and industry peers alike. Thank you to NewBeauty for the recognition!
Cetaphil®, the leading dermatologist-recommended sensitive skincare brand, is launching ‘Face of Cetaphil®’, a first-of-its-kind global skincare immersion. This immersion will put the sensitive skin science behind its formulas to the ‘ultimate skin stress test’ at New York fashion week. As an extension of the brand’s ‘We Do Skin, You Do You’ campaign, Cetaphil’s activation enlists influencers and consumers from 14 different countries to be the ‘Face of Cetaphil’ who will participate in 48 hours of fashion week events and activations putting Cetaphil’s sensitive skincare formulas to the test.
It’s an exciting time for aesthetics. Aesthetic treatments are increasingly becoming part of holistic beauty and well-being routines, and the market is predicted to nearly double in value and reach $25.9B by 2028. At Galderma, we know that aesthetic procedures have a profound impact on people’s lives, and knowledge and education play a pivotal role in steering them toward positive outcomes. A key way in which we tackle this challenge is through close collaboration with experts in the aesthetics community. Our new trend report, NEXT by Galderma, is the product of research commissioned by Galderma in collaboration with leading trend forecasting agency WGSN, and co-created with a global network of renowned aesthetic practitioners and influencers. It builds on our trust-based relationships with the dermatology community, and we would like to express our heartfelt gratitude to everyone who devoted their time and insights to this report. By examining the direction in which the aesthetics market is evolving and identifying future needs and expectations together, we can all work proactively to drive a better experience for patients and consumers.
Galderma is, first and foremost, a growth story. In the fast-evolving dermatology market, we have established ourselves as a transformative and global industry leader with a dedication to innovation, patient-centricity and to advancing skin health. As we continue our growth journey and expand our reach and impact, every single person at Galderma will play a pivotal role in shaping not just Galderma’s future, but also the future of skin health – one breakthrough at a time. Learn more about how we continuously strive for accelerated growth:
As the pure-play dermatology category leader, we’re committed to delivering impactful, science-based treatments. That’s why we proudly feature Restylane® as one of the key differentiators of our high-performing portfolio. With the most diverse range of gel properties on the market, Restylane is more than a testament to our advanced R&D – it’s also part of a fascinating legacy. 30 years ago, Restylane scientists leveraged their advanced expertise to innovate upon the hyaluronic acid (HA) molecule. The result? An effective, long-lasting filler that would forever transform the global injectable aesthetics market. We visit our site in Uppsala to hear from our experts Per Winlöf and Per Andersson on their amazing discovery. Watch the video to hear about their journey.
At Galderma, our dedication to giving back not only manifests itself in our purpose: advancing dermatology for every skin story. It extends to our focus on making a meaningful difference in our communities. Since 2012, we’ve been proud partners of Children's Skin Disease Foundation/Camp Wonder. Through Camp Wonder, CSDF provides children living with severe skin conditions the chance to just be a kid. Each year, campers experience a week of fun and self-discovery, while building a community that lasts a lifetime. Over the past 11 years, Galderma has donated more than $1.8 million, 50,000 Cetaphil products and provided dozens of annual on-the-ground volunteers to CSDF to support Camp Wonder.
"Our people are the special sauce at Galderma.” That’s how our National Sales Director in the U.S., Ruben Gonzalez, describes the diverse skills and perspectives of our people. We recognize each individual’s vital role in Galderma’s journey to becoming the world's leading dermatology company. And to celebrate our exceptional teams, we are shining a spotlighting on stories – from professional growth to taking part in innovative product development. Read more about Galderma's high-performance culture and what it means to our people.
